Conn. gets $755K share of nationwide Medicaid fraud settlement
HARTFORD, Conn. (Legal Newsline) - Four drug makers accused of
defrauding Medicaid will pay the state of Connecticut $775,000 as part of a nationwide settlement.
Mylan Pharmaceuticals, Inc., and its related company UDL Laboratiories, Inc., will pay $745,000 to the state. Ortho McNeil will pay an additional $9,000 and AstraZeneca will pay $21,000.
The companies are alleged to have failed to pay required rebates for certain drugs that were provided to Medicaid recipients.
"This settlement sends a powerful message: We will vigilantly and vigorously police state healthcare programs to assure drug companies fulfill their contractual and financial obligations to taxpayers," Attorney General Richard Blumenthal said.
The payments come as part of a $124 million settlement between the drug companies, numerous states and the federal government.